Same review, same sources, same scoring — the summary and the reasoning open together on each row.
4. Premier Hormone Health & Wellness
$99/mo — printed as "From $99 / month" on the peptides page's PT-141 card, a floor rather than a quoted rate; the card describes on-demand use and does not say what the monthly figure includes
Summary, strengths and trade-offs8 points
Premier draws the line between the platform company and the medical practice more explicitly than anything else on this roster. Its peptides are priced on catalog cards, and its sermorelin page prints no figure.
Strengths
- States that the company is a non-clinical platform and that the practices it supports are independently owned
- Prints a figure and its period on every card of its peptide and general wellness catalogs
- Prices sermorelin and tesamorelin separately for men and for women, each as a monthly starting figure
- Says its compounding pharmacies are US-based and describes the standards claimed
Trade-offs
- Its peptide figures are starting prices on catalog cards, and no card says what its figure includes
- The sermorelin page itself prints no figure and says only that the initial assessment will outline all costs
- Names no dispensing pharmacy
- Its state coverage is a one-line footer claim of serving all states, with no list behind it
5. TeleZen MD
$198/mo — per month after the first month, which is $148 — the plan block reads "Monthly Plan / $148 first month / $198 /month after"
Summary, strengths and trade-offs8 points
TeleZen MD, a Florida limited liability company, publishes a first-month rate and the ongoing rate for four compounds, and puts a quarterly, semi-annual and annual lane beside the monthly one on its NAD+ and glutathione pages.
Strengths
- Prints the first-month rate and the ongoing rate together on every treatment page, rather than the introductory one alone
- Publishes four plan lengths on the NAD+ and glutathione pages with the total charge shown next to each per-month figure
- Answers the coverage question directly in its FAQ instead of leaving state availability to the intake
- Prices the nasal-spray route separately from the injection at two strengths
Trade-offs
- Says outright that patients do not choose the dispensing pharmacy and that its pharmacy partners may change at any time
- Names no pharmacy anywhere, describing them only as independent licensed 503A facilities
- Runs three stacked promotional codes on the same page, so the figure a reader sees first is rarely the plan rate
- Describes no lab work as included at any plan length
6. RxPepsDirect
$75 — pharmacy price for one vial at wholesale, billed by Optimal Balance Pharmacy, plus a separate $39 medical visit per order and $15 flat shipping; the catalog states no supply length
Summary, strengths and trade-offs9 points
RxPepsDirect charges one $39 fee per order for the medical visit and then steps out of the transaction: Optimal Balance Pharmacy bills the patient directly at its own wholesale price, and that price is printed for every peptide on the site.
Strengths
- Names both the dispensing pharmacy (Optimal Balance Pharmacy, a Texas 503A) and the outside laboratory that tests each batch (Eagle Analytical Services), and publishes the batch reports
- Lists all 29 licensed states by name in its FAQ rather than only printing the count
- Separates its own fee from the medication entirely: $39 per order for the visit, with the pharmacy billing the drug at wholesale and adding $15 flat shipping
- Every peptide price is readable without an account, combination vials included
Trade-offs
- The figure is a per-vial pharmacy price, not a monthly one — the BPC-157 page itself says one vial lasts about five weeks
- KPV is not sold on its own; it is only available inside BPC-157 combination vials
- Semax is sold only as a Semax/Selank nasal spray, so its figure is a combination price
- Caps an order at three different peptides, so a wider protocol needs a second $39 visit
- Its FAQ says the company was founded in 2026, so there is very little independent history behind the pharmacy-at-cost claim
7. MultiGen Wellness
$156.75 — Per vial — read from "PT-141 (Bremelanotide) 2mg/mL 10mL Vial ❄ Refrigerate $156.75". No dosing frequency is published beside it, so the figure cannot be converted to a month
Summary, strengths and trade-offs8 points
MultiGen publishes a per-SKU formulary with the strength, the package size and the storage temperature on every line — and closes it by disclosing its own markup over compounding cost, which nothing else here does.
Strengths
- Publishes a full formulary with strength, package size, storage temperature and price on every row
- Discloses its own markup over compounding cost in plain words, which nothing else on this roster does
- Prices shipping separately and visibly instead of folding it into the medication figure
- Answers the regulatory-status question per compound rather than with one blanket sentence
Trade-offs
- Mixes per-vial and per-month units in the same summary list, so the cards and the table are not comparable to each other
- Publishes no corporate entity at all — a trading name and a Texas address is the whole disclosure
- Names no dispensing pharmacy, describing it only as "our FDA-compliant compounding pharmacy"
- Markets a peptide it does not stock: BPC-157 appears in its prose and its FAQ but not in its formulary
8. Pepti
$259 — vial price; the catalog says the supply varies by dose rather than naming a four-week quantity
Summary, strengths and trade-offs8 points
Pepti prints one all-in monthly figure for every treatment it sells, in two formats side by side, and it is the only roster row that publishes both a fifty-state footprint and a price for epitalon.
Strengths
- Prints an all-in monthly figure on every treatment card and states that no membership fee sits on top of it
- Names the unit each figure covers, so a four-week supply is never left to be guessed at
- Quotes a pen and a vial price side by side, which makes the format premium visible instead of buried in checkout
- States its own coverage as all 50 states and Washington, D.C. in its site footer
Trade-offs
- Bloodwork is a separate charge rather than part of the monthly figure, though recent labs can be uploaded instead
- The 503A/503B compounding pharmacy it uses is described but never named
- The PT-141 card gives no supply length, so its figure is the only one on the catalog that cannot be read as four weeks
- CJC-1295, ipamorelin and TB-500 are sold only inside combination vials
9. PeRx
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
PeRx, the trading name of Wellness MD Group PC, lists twenty-six compounds and blurs the price on every one of them, publishing a floor and a range on a separate pricing page instead.
Strengths
- Tied for the widest compound list on this roster, with each blend spelled out into its constituent peptides on its own page
- Publishes a floor and a range in ordinary body copy, so a reader can bound the cost without an account
- Names its operating company and its trading name in the first paragraph of its own terms
- Says in its terms that it ships to every state, and repeats the claim as a headline figure
Trade-offs
- Blurs the per-compound price on every product page and marks it hidden from screen readers, so no individual compound has a readable figure
- Its own pricing page contradicts itself on the consultation fee, listing "no separate consultation fee" among what every order includes and then answering twice that consultations are $50
- Says all sales are final once an approved prescription is charged
- Names no dispensing pharmacy, only the category
10. FormBlends
$170/mo — "PT-141 (Bremelanotide) Monthly Plan / $170 billed monthly"; the cadence selector above it reads "Monthly $170 /mo $170 \u00b7 Every 3 months Save 10% $153 /mo $459 \u00b7 Every 6 months Save 15% $145 /mo $867 \u00b7 Every 12 months Save 20% $136 /mo $1,632" \u2014 the three lower per-month figures are divisions of those totals. Served from after a redirect from /products/pt-141
Summary, strengths and trade-offs8 points
FormBlends names its three dispensing pharmacies with their cities and designations, prices seven of the compounds compared here on one-month plans, and publishes a state-by-state map it dates and sources to its own last hundred and sixty-five shipped orders.
Strengths
- Names three dispensing pharmacies with their cities, legal names and designations
- Publishes a dated state map and says the count comes from its own shipped orders rather than a marketing claim
- Prints a one-month plan whose per-month figure is also what is charged that month
- Says plainly that shipping is included and lab work is not
Trade-offs
- Quotes per-month figures on its longer plans that are divisions of the amount actually billed
- Buries seven product pages inside a sitemap of more than a hundred thousand article URLs
- Sells one of the compounds compared here only inside a two-compound blend
- Redirects one product address to a different one, so a cited URL and a read URL can differ
11. PharmaZee
$175/mo — recurring monthly on the 1-Month Supply tab; the same panel prints a first month of $110.00
Summary, strengths and trade-offs8 points
PharmaZee prices five tracked peptides with a first-month figure and a recurring figure printed side by side, names its two filling pharmacies, and carries a 2026 federal warning letter.
Strengths
- Prints the first-month figure and the recurring figure together, so the introductory rate is not disguised
- Prices five products covering four tracked compounds, including two routes of the same one
- Names both filling pharmacies with street addresses in its FAQ
- States the concentration and bottle size on the products where those differ
Trade-offs
- Carries a federal warning letter that names this exact domain
- Hides the pharmacy names and the coverage answer inside collapsed accordions
- Publishes no state list and answers the coverage question with named prescribers instead
- Serves no sitemap, so the product list can only be found through the navigation
12. PlexusDx
$189/mo — per month flat, in the seller's words "no commitment tiers, no per-dose surcharge" — one charge covering "your provider visit, prescription, medication, and shipping"
Summary, strengths and trade-offs8 points
PlexusDx sells five of the six compounds this site ranks — sermorelin, NAD+, glutathione, GHK-Cu and PT-141 — each as an all-inclusive monthly program, and it is one of only seven sellers here that reaches the PT-141 board at all.
Strengths
- Reaches five of the six compounds this site ranks, one of seven sellers here to reach five or more
- States on every program page that the monthly price does not change as the dose changes
- Names the three commitment tiers and their per-month rates side by side instead of advertising only the cheapest
- Offers GHK-Cu as a topical cream and glutathione as a nasal spray or troche, so two of the five need no injection
Trade-offs
- Publishes its own corporate name two different ways — "PlexusDx, Inc." in one terms document and "PlexusDX LLC" in the other
- The glutathione page states both a 46-state and an all-50-state footprint without resolving which applies
- No compounding pharmacy is named on any of the five product pages
- Five states are said to require a scheduled video visit rather than the async intake, but the page never lists which five
13. AgelessRx
$199/mo — per month ongoing; the first month is $149
Summary, strengths and trade-offs9 points
AgelessRx publishes a short, deliberately curated peptide menu and names four compounds it has decided not to sell yet — but every headline figure on it is a first-month rate with a higher number behind it.
Strengths
- Names BPC-157, TB-500, MOTS-c and KPV on its own peptide page as compounds it has chosen not to sell yet, which is rare candor in this category
- Publishes the ongoing rate alongside the introductory one on three of its five peptide pages
- Sells PT-141 and sermorelin in both an injection and a nasal spray rather than a single format
- Says a plan can be paused or canceled at any time
Trade-offs
- Every headline figure on the site is a first-month rate, and the ongoing rate runs $50 to $70 higher
- The GHK-Cu cream page prints the same figure as both a first-month price and an ongoing one, so the two disagree on one page
- The glutathione page gives only the three-month-plan rate, leaving the plain monthly price unpublished
- The compounding pharmacy that fills prescriptions is not named, and no state list is published
- A competition ranking is quoted on the site as a credential; it is marketing, not an independent assessment of the products sold
14. Valhalla Vitality
$200/mo — plans start at, per month; the same page offers an injection and a nasal spray at that figure
Summary, strengths and trade-offs8 points
Valhalla Vitality lets the patient choose which pharmacy fills the prescription and says the price does not change either way.
Strengths
- Lets the patient pick which verified pharmacy fills the prescription
- Says the price is the same whichever pharmacy is chosen
- States that compounded drug products are not approved or evaluated by the FDA
- Says it serves 50 states nationwide
Trade-offs
- Publishes a figure for only one of the four compounds it sells
- Publishes no operating company on any page read
- Names none of the pharmacies it invites patients to choose between
- No certificate of analysis is reachable
15. Eviora MD
$249/mo — the "PT-141" card prints "from $249/mo" — a starting floor; the card states no dose or delivery form
Summary, strengths and trade-offs12 points
Eviora MD prints a monthly starting figure on every card of an open twenty-card peptide menu, sells eight tracked peptides on their own, and publishes no price for its GLP-1 programs.
Strengths
- Prints a monthly starting figure on every card of a twenty-card peptide page, with no quiz, account or email gate in front of it
- Sells eight tracked peptides as single products, so those figures can be set against other sellers
- Bills each subscription as one total, which its terms split between the pharmacy, the medical group and the platform
- States fifty-state service in its FAQ and on its About page
- Lists the five cases in which it refunds, one of them a provider declining to prescribe
Trade-offs
- Every figure is a floor written as "from", and only the NAD+ card names a form; no card states a dose
- CJC-1295, ipamorelin, TB-500, KPV and Semax appear only inside stacks, so none has a price of its own
- Several stack cards reuse a single peptide’s description — the four-peptide BPC-157 stack is described only as a copper peptide
- Its semaglutide, tirzepatide and microdose programs publish no price on their own pages
- Its homepage, program pages and terms give three different cancellation terms
- The pharmacy, the medical group and the prescriber all go unnamed
- Its peptide page follows the same template, card list and most of the same figures as other storefronts on this site, so it is not an independent reading of the market
16. New Wave Health
$249/mo — from, per month
Summary, strengths and trade-offs14 points
New Wave Health prints a monthly starting figure beside every product on a twenty-item peptide menu, and sells compounded semaglutide and tirzepatide with no price on either.
Strengths
- Puts a monthly starting figure beside every product on its peptide menu, with nothing advertised without one
- Names its operating company in its terms and prints a street address, a phone number and a support email for it
- Its terms promise an electronic notice 5 to 7 days before every recurring charge, and let a subscriber switch off auto-refill in the portal
- Lists the grounds on which it refunds, including a provider who declines to prescribe
- States under the menu that compounded medications are not FDA-approved
- Checked against FDA's warning-letter record in September 2026: no letter found under its name
Trade-offs
- Every figure is a floor written as "from", and nothing says what moves a program above it
- TB-500, KPV, CJC-1295, ipamorelin and semax are sold only inside combination products, so none has a price of its own
- Seven of its nine combination products carry the description of their first ingredient alone
- Its menu lists the same twenty products at the same figures as another storefront in this comparison that trades under a different company name
- Sells compounded semaglutide and tirzepatide with no price on either drug page
- Names no pharmacy and no prescriber, and its terms call the company a technology platform that does not practice medicine
- Its homepage says all 50 states while its program pages say Virginia and the states where its providers are licensed, without naming them
- Its FAQ says it never sells or shares data; its California privacy notice says it may have sold or shared identifiers and browsing data with advertising networks
17. RX Bella
$249/mo — printed as "PT-141 · from $249/mo", a floor rather than a quoted rate
Summary, strengths and trade-offs9 points
RX Bella prints a monthly starting figure on every card of a twenty-protocol peptide menu and on its two GLP-1 injections. Nine of those protocols are stacks priced as one, and no card names a dose.
Strengths
- Prints a monthly floor on every one of twenty peptide protocols, grouped by goal, on an open page with no quiz or account in front of it
- Sells eight tracked peptides as single products, not only inside combinations, and prices semaglutide and tirzepatide on its home page
- Its terms say the subscription is one bundled charge covering the drug, the provider and the platform, with no separate membership fee
- Names its operating company, RX Web Meds LLC, with a mailing address, and lists the exact grounds on which it refunds
Trade-offs
- Every figure is a floor written as "from", and no card names a dose, a vial size or, apart from the NAD+ card, a delivery format
- Nine protocols are stacks priced as one, and some reuse a single peptide's description: the four-peptide BPC-157 blend is described as a copper peptide for skin and hair
- Its peptide menu repeats another telehealth brand's page, and every product the two share carries the identical figure, so the two are not independent prices
- Names no compounding pharmacy and no clinician, and its all-50-states claim is hedged by its program pages and terms, which publish no list
- Its program pages and its terms give different cancellation notice periods
18. HealthHub
$99 — "PT-141 Injectable, from $99 / An on-demand subcutaneous injection used before activity, with the dose set by your provider. Includes your online consult, medication, supplies, and discreet shipping." Named no supply period at all — the seller calls it on-demand rather than a course
Summary, strengths and trade-offs8 points
HealthHub answers the pharmacy question with six named facilities and their street addresses, and prices three of the compounds compared here in five preparations, every one of them on a four-week supply rather than a calendar month.
Strengths
- Names six compounding pharmacies with their street addresses on the product pages themselves
- Says exactly what each figure covers — consult, medication, supplies and shipping
- Prices three preparations of one compound separately rather than quoting one rate for all
- Answers the lab-work question plainly instead of leaving it to the intake
Trade-offs
- Renders a long price table of unrelated medications on every product page, none of it the product being read
- Quotes four-week supplies while most sellers quote months, so its figures need converting before they compare
- Publishes no statement at all about which states it serves
- Prices its on-demand compound from a floor rather than at a rate
19. CLYR Health
$119 — the one-month tier; a three-month supply is $199 billed once
Summary, strengths and trade-offs8 points
CLYR Health prices seven tracked compounds by weekly dose with the whole ladder visible before any intake, names its pharmacy, and puts a competitor's cream price in the same table as its own.
Strengths
- Prices seven tracked compounds with the full ladder visible before any intake
- Prints the vial size, concentration and weekly dose beside each figure
- Names its dispensing pharmacy and its medical group
- Its savings arithmetic reconciles against every multi-vial total it prints
Trade-offs
- Puts a competitor's cream price in the same table as its own
- Its tirzepatide hero quotes a cycle rate the ladder below contradicts
- Its LegitScript badge links to its own article rather than to a listing
- Says only that the service is available in certain states, without naming any
20. Lifeforce
$160 — per 25 days, not per month — the same "25 Days" purchase option and "Ships every 25 days" wording as this seller's sermorelin page; sold only to members of a $149/month membership and requiring a one-time $599 diagnostic, neither of which is included in this figure
Summary, strengths and trade-offs9 points
Lifeforce sells peptides only to members, bills them every 25 days rather than monthly, and puts a paid membership and a one-off diagnostic in front of the first order — three separate figures that are never added together on the page.
Strengths
- Publishes a positive eligible-state list on each product page rather than a coverage sentence, and the two lists are different, which most sellers here never disclose
- Names the operating company, its address and California as the governing law, and separately names each clinical practice entity by state
- States the membership fee, the diagnostic fee and the medication charge as three distinct figures rather than one blended number
- Prints the shipping interval in days on the purchase option itself, so the period is not left to inference
Trade-offs
- Bills every 25 days, which is neither weekly nor monthly, so the figure cannot be set beside a monthly price without converting it
- The medication figure is not the cost of access: a $599 diagnostic and a $149 monthly membership come first, and the page never adds the three together
- Its eligible-state list for PT-141 is four states shorter than its list for sermorelin, so coverage has to be checked per compound
- The pharmaceutical catalog is labeled members only and its category pages show no price at all, so a shopper who stops at the catalog sees nothing
- No compounding pharmacy is named
21. Pomegranate Health
$175 — read as the product-page heading "Men's Health | PT-141 Compound | From $175 | Boosts desire, enhances arousal, deepens experience" — this is the one product on this seller where the figure carries no billing period; its three longevity siblings all print "/month" and this one prints "From" and stops. It is filed under a different service line, and the page names no dose, no quantity and no term
Summary, strengths and trade-offs9 points
Pomegranate gives each compound its own page with a single monthly figure in the heading, and its terms name the territory it serves rather than leaving availability to be discovered at intake — but the figure for its one non-longevity peptide carries no period at all.
Strengths
- Gives each compound its own product page with one figure in the heading instead of a range or a ladder
- Names the territory it serves in its terms, including two territories beyond the fifty states
- Answers the lab question in its own words rather than leaving it unaddressed
- Publishes the same product list in its navigation and its footer, so the range is visible from any page
Trade-offs
- The one product outside its longevity line carries no billing period at all, while its three siblings all print a monthly one
- No dispensing pharmacy is named — the site badge reads only "FDA-Regulated Pharmacies", which describes a category
- The lab answer says lab testing is often an important part of care, which is the opposite of saying it is included
- The fifty-state claim is immediately qualified by a sentence saying certain services and medications may not be available in certain jurisdictions
- The lab and treatment answers sit inside a collapsed accordion and are absent from the page until it is clicked open
22. Robertson Wellness Center
$199 — Per bottle, and the bottle is twice the size of most on this page — "PT-141 … 20 mg bottle $199"
Summary, strengths and trade-offs8 points
Robertson publishes a per-bottle catalog with the milligrams printed on every line, and opens it by telling readers it has discontinued peptides because of a federal change to what compounding pharmacies may make.
Strengths
- Prints the strength on every single price line, so per-milligram comparison is actually possible
- Tells readers a regulatory change has removed peptides from its list instead of quietly deleting them
- Prices its consultation separately and visibly
- Names the oral forms as capsules and prices them per pack rather than pretending they are vials
Trade-offs
- Publishes no corporate entity — a trading name, a Beverly Hills phone number and nothing more
- Does not say which peptides the regulatory change removed
- Sells CJC-1295 and ipamorelin only as one blended bottle, so neither has a price of its own
- Publishes no state coverage and names no dispensing pharmacy
23. Rejuvia Wellness
$240 — per vial, printed as $240 in the table's "VIAL" column beside a course of "1 vial / 1 month"; the page says vials start at $240, and this course is a single vial
Summary, strengths and trade-offs8 points
Rejuvia prices its peptides by the vial and prints beside each figure how many vials a course takes and how long it runs. The cost of a full course is mapped out at the consultation, not printed.
Strengths
- States the vial count, the milligram strength and the course length beside every vial price
- Publishes a figure for eight separate tracked compounds
- Charges nothing for the initial consultation and says so
- Marks each course as a standard or premium tier rather than blending them
Trade-offs
- Each figure is the price of one vial, and most courses take more than one, so no figure on the table is the cost of a multi-vial course
- Publishes no corporate entity on any page read
- Charges separately for the initiation visit on top of every course
- Publishes no state list and names no dispensing pharmacy
24. Vitalex Health
$249 — from, per month — a floor rather than a quoted bill
Summary, strengths and trade-offs8 points
Vitalex Health publishes the broadest open peptide price list read in this pass — twenty priced protocols across six goal areas, singles and stacks alike — on a page that ships the same template, the same headline and two identical figures as another seller entering this roster the same day.
Strengths
- Prices seventeen distinct protocols in visible text on one open page, with no quiz, account or gate in front of any of them
- Groups the catalog by goal rather than by compound, and names the exact combination in every stack
- Prices the stacks as well as the singles, so a reader can see what adding a peptide actually costs
- Claims fifty-state service for itself with a number on its own About page
Trade-offs
- Its peptide page is the same template, headline and disclaimer as another seller on this roster, with two figures identical to the dollar — the two are not independent readings of the market
- Every figure is a "from" floor, so none is a quoted monthly charge
- CJC-1295, ipamorelin, TB-500, KPV and Semax are sold only inside stacks and are never priced alone
- No compounding pharmacy is named anywhere, and the disclaimer places prescribing entirely with independent third parties
25. Invigorate Advanced Aesthetics
$250 — No unit is published — "PT-141 | Enhances sexual desire and arousal for men and women | $250"
Summary, strengths and trade-offs8 points
Invigorate publishes a per-compound price for eleven peptides and attaches no unit to any of them — not a vial, not a month, not a dose — on a page that prints the same list twice in two different orders.
Strengths
- Publishes a per-compound figure for eleven peptides rather than one starting rate
- Prints the catalog as a proper table as well as a card grid
- Prices blends as their own lines instead of implying them from the singles
- The price list sits on the service page itself, not behind an intake
Trade-offs
- Not one figure carries a unit — no vial size, no dose, no billing period
- The card grid prints prices before the names they belong to on about half the rows
- Publishes no corporate entity; the only company named on the legal page is its web agency
- Names no dispensing pharmacy and publishes no state coverage
26. SynergyRx
$275 — starting at, the bottom of a range; the catalog names no billing period
Summary, strengths and trade-offs8 points
SynergyRx prices four tracked peptides at exactly the same figure and its two GLP-1s separately, prints that figure before the product name rather than after it, and runs terms of service naming a different company as the operator.
Strengths
- Puts a figure beside four separate tracked peptides rather than behind one category floor
- Says plainly that it neither manufactures nor dispenses what it sells
- Prices PT-141, which few sellers on this roster price at all
- Publishes its catalog without an intake in the way
Trade-offs
- Prices four different peptides at exactly the same number, with no dose or vial size to separate them
- Its terms of service name a different company as the operator throughout
- Publishes no price for either weight-loss molecule
- Will not publish its state list, directing readers to customer service instead
27. PeptidesRx
$318 — "PT-141 / Bremelanotide. Injection or nasal spray. / from $318 per vial / $811 for 3 months". The WooCommerce catalog prices it at "$ 289.00".com/product/pt-141/
Summary, strengths and trade-offs8 points
PeptidesRx prices ten of the compounds compared here, names the pharmacy that fills the orders and gives its address, and runs two live catalogs on one domain whose figures do not agree with each other on a single compound.
Strengths
- Prices ten of the compounds compared here, more than any other seller on this roster
- Names its dispensing pharmacy, its street address and its telephone number
- States the vial strength and the expected duration of a vial beside most figures
- Publishes the states its pharmacy is not licensed in rather than only the count
Trade-offs
- Runs two live catalogs whose figures disagree on every compound they share
- Prints a third, templated figure on every product page that belongs to no product
- Gives two coverage numbers in one paragraph that cannot both be right
- Prices a third figure for one compound on a marketing page separate from both catalogs
28. Bayan Health
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Bayan Health is one of the few sellers anywhere on this roster that publishes a KPV price, and it bills that price monthly across a fixed three-month protocol.
Strengths
- Publishes a KPV price, which almost nothing else on this roster does
- States both the monthly charge and the three-month commitment on the same line
- Says the physician consultation fee is included in the monthly price
- Describes its supply in its own words as "U.S. 503A pharmacy partners"
Trade-offs
- Publishes no operating company on any page read
- Sells five more tracked compounds without publishing a figure for any of them
- Ships the whole three-month protocol at once while billing across three months
- Publishes no state list, names no pharmacy and posts no certificate of analysis
29. Better Med Spa
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Better Med Spa sells epithalon and GHK-Cu only as one combined protocol at one price, and attaches no billing period to any figure it publishes.
Strengths
- Names thirteen tracked compounds, one of the deepest menus on this roster
- Publishes a figure on each individual treatment page rather than gating them
- Gives epithalon and GHK-Cu a dedicated page rather than burying them in a list
- Separates its NAD+ IV from its at-home and in-office shot plans
Trade-offs
- Attaches no billing period to any peptide figure, so none can be compared
- Sells epithalon only bundled with GHK-Cu, so neither has a price of its own
- Its legal company name shares no words with its brand
- Publishes no state list and names no dispensing pharmacy
30. JRNYS
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
JRNYS prints each longevity product's price only on the other product's page — read either one alone and the NAD+ and glutathione figures come out reversed.
Strengths
- Prices NAD+, glutathione and a tirzepatide microdose separately rather than behind the membership floor
- Names its microdose product as a microdose rather than as a full dose
- Says plainly in its terms that prescriptions may move between pharmacies
- Publishes a longevity index that lists every product and figure in one place
Trade-offs
- Each longevity product page prints its neighbor's price and none of its own
- Its FAQ says pricing is confirmed after consultation while its pages publish fixed figures
- Names no dispensing pharmacy, and says the dispenser can change without notice
- Makes no state-coverage claim on the pages read
31. NexLife
Does not publish a PT-141 price.
Summary, strengths and trade-offs11 points
NexLife lists two peptide products and neither one can be bought: one shows a real price above a sold-out button, the other shows a zero. The rest of the catalog is GLP-1, and the company carries an FDA letter that names this exact domain.
Strengths
- Publishes a list price on the peptide product page rather than hiding it behind an intake
- Marks stock status on the product itself, so an unavailable item is visibly unavailable
- States a fifty-state claim in plain words in the first answer of its FAQ
- Names its operating company in the disclosure on every page
Trade-offs
- Carries an FDA warning letter that names this company and this exact domain
- Both peptide products are marked sold out, so neither published figure can currently be acted on
- The second peptide product publishes a zero as its price, which is a storefront default and not an offer
- The sermorelin figure carries no strength, no quantity and no billing period, so it cannot be compared to a monthly program rate
- No dispensing pharmacy is named — the answer is that every pharmacy holds certifications, which describes a standard and not a supplier
- The FAQ answers that would name the pharmacies and the prescribers sit inside collapsed controls that did not open on repeated attempts
- No lab work is included in or priced beside any product
32. Next Vial
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Next Vial names its pharmacy with a street address and lists the forty-nine states it serves, and then hides every price but one behind a plan selector.
Strengths
- Names its dispensing pharmacy with a street address and a telephone number
- Lists the forty-nine states it serves rather than printing a count
- Names the clinician network that reviews the intake
- States plainly that compounded medicines are not FDA-reviewed
Trade-offs
- Four of its five peptide products show a plan selector where a price should be
- Its weight-loss floor covers two different drugs behind one figure
- The one published figure names no billing period
- Alaska is absent from its own state list, so the coverage is not nationwide
33. Oasis Medical Clinic & Spa
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Oasis splits its consultation charge into a deposit and a balance, so the first figure on its peptide page understates even the visit. Of the compounds on that page, it prices only NAD+, as an IV therapy in its online shop with no dose stated.
Strengths
- States the full cost of the first appointment in one sentence, in two parts
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Prices NAD+ only as an IV therapy with no dose stated, and the two consultation figures are easily read as one
- Prices no peptide; its online shop says its peptide products are unavailable
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
34. PeptideMD
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
PeptideMD prices peptides by tier rather than by molecule, and its homepage and its pricing page quote two different figures for the same single-peptide tier.
Strengths
- Says which pharmacy class compounds its medication and that shipping is cold-chain
- Includes a baseline lab panel in its higher peptide tiers and says so on the page
- Publishes a full pricing page rather than gating rates behind intake
- Quotes two- and three-month terms alongside the one-month rate
Trade-offs
- Its homepage and its pricing page disagree on the price of its own entry peptide tier
- Peptide pricing is per tier, so no figure attaches to any named molecule
- Publishes no corporate entity on any of the four pages read
- Publishes no state list and names no dispensing pharmacy
35. Solas Health & Wellness
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Solas publishes no corporate entity and instead puts one named, licensed clinician on every page — and prices peptides per cycle rather than per month, which is a unit almost nothing else here uses.
Strengths
- Publishes a per-cycle range as well as a starting figure, so the spread a buyer faces is visible
- Puts one named, licensed clinician on the pages and states the two states she is licensed in
- Says the consultation fee is credited toward the first cycle rather than charged on top
- States plainly that no membership, enrollment or hidden fees apply
Trade-offs
- Publishes no corporate entity anywhere on the pages read
- The peptide price is per cycle, and the only cycle length it publishes is a four-to-twelve-week range on its blog, so it cannot be compared with a monthly rate
- Names no dispensing pharmacy, describing them only as licensed compounding pharmacies
- Its NAD+ figures use two different units — four injections for one price, and a single infusion for another
36. Team Wellcore
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Team Wellcore names its dispensing pharmacy with an address, a phone number and the ten states that pharmacy cannot ship sterile compounds into — and then charges for a consult before it will quote the price of any medication.
Strengths
- Names the dispensing pharmacy with a street address and a phone number rather than describing a class of facility
- Names the ten states that pharmacy cannot ship sterile compounds into, which is a checkable exclusion list rather than a coverage claim
- States the consult charge up front and says the medication is billed only after a provider approves
- Describes its compounded products as patient-specific and not FDA-approved in its own FAQ rather than burying the point
Trade-offs
- Four of its six tracked products publish a price only inside structured data, where no reader ever sees it
- Where a visible figure and a structured-data figure both exist they disagree, and the visible one is the higher
- Its own state arithmetic is wrong — it claims licensure in forty-four states while naming ten it is excluded from
- No visible figure carries a billing period, so nothing it publishes can be read as a monthly rate
37. Vita Bella
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Vita Bella prices NAD+ against IV clinics in a two-column table, and both of its own figures are conditioned by a footnote most readers will skip.
Strengths
- Names Vita Bella Health LLC as the operating company
- States the vial size and the number of injections it contains
- Publishes its footnote conditions on the same screen as the figures
- Sells four tracked compounds rather than one
Trade-offs
- Its headline per-shot figure requires a membership whose price is not on the page
- Prices only NAD+ — its sermorelin, tesamorelin and PT-141 carry no published figure
- Describes a "US FDA-Inspected Pharmacy" without naming one
- Its comparison column is a competitor category, which is easy to misread as its own price
38. Rebody Health
$109/mo — per month after the first month, which is $54.50 — the page reads "PT-141 mini troches, 1 mg or 2 mg, eight to a jar. $54.50 your first month, then $109."
Summary, strengths and trade-offs8 points
Rebody Health, operated by Compound Technologies, Inc., prices five compounds across injection, nasal spray, troche and cream, and prints the ongoing rate beside the first-month rate on every product page instead of only the discounted one.
Strengths
- Prints the recurring rate beside the discounted first month on every product page, so the ongoing cost is readable before checkout
- Enumerates its jurisdictions state by state in its terms, District of Columbia included, rather than asserting a count
- Sells one compound in more than one route — sermorelin, NAD+ and PT-141 each have an alternative to the needle, priced separately
- States in its terms that the consultation fee sits inside the plan price and names the amount
Trade-offs
- Names no compounding pharmacy — its terms say only that orders are dispensed by independent licensed pharmacies
- The injectable NAD+ line bills in two-month blocks, so its advertised per-month figure is a division rather than a charge
- Every headline figure on the site is an introductory one, and the ongoing rate is roughly double it on most products
- No lab work is described as included at any tier
39. Hone Health
$130/mo — read as the visible heading "PT-141 for Men $130/mo + membership" — the "+ membership" is the seller's own words and is not optional: the same page prints "Hone offers two memberships: Basic – $25/month … Premium – $155/month", so the lowest total is the medication rate plus $25/month and no single figure on the page is the cost of therapy
Summary, strengths and trade-offs8 points
Hone prints its peptide rate with the words "+ membership" attached to it, and publishes two membership tiers elsewhere on the same page — so the advertised figure is one of two numbers a buyer pays, and the page says so.
Strengths
- Names its operating company and five separate independently owned prescribing entities in one sentence of its own terms
- Prints "+ membership" beside the medication rate instead of leaving the second charge for checkout
- Publishes both membership tiers, with what each one includes
- States that its lab panel is a separate purchase and prices it on the same page
Trade-offs
- The headline rate is not the cost of therapy — a membership at $25 or $155 a month sits under it
- No dispensing pharmacy is named anywhere on the pages read
- The terms decline to say where the service is available, saying only that it may not be available in your state
- The LegitScript claim is the seller's own assertion on its own page and was not independently confirmed here
40. Magnolia Regenerative Medicine
$135/mo — starting at, per month; monthly and quarterly options offered
Summary, strengths and trade-offs8 points
Magnolia Regenerative Medicine publishes a flat per-compound rate for twelve of the peptides this site tracks, on one catalog page, with the billing cadence printed beside each figure.
Strengths
- Prices twelve tracked compounds individually on one catalog page instead of behind an intake
- Prints the billing cadence beside each figure, so a quarterly item is visible as one
- Names Magnolia Regenerative Medicine Health LLC as the operating company in its own footer
- Separates single-compound products from its blends by name, which makes a scoped price readable
Trade-offs
- Publishes no list of states it serves
- Names no dispensing pharmacy; its comparison table says only "US FDA-Inspected Pharmacy"
- Sells five of the compounds it stocks only inside blends, so those carry no scoped price
- No certificate of analysis is reachable
41. Mirabel Meds
$224/mo — printed as "PT-141 · from $224/mo" — a floor rather than a quoted rate
Summary, strengths and trade-offs7 points
Mirabel Meds publishes a wide peptide menu with a monthly figure on every product, and prices five of them as multi-peptide stacks rather than as single compounds.
Strengths
- Puts a monthly figure on every product in a wide menu, with the period printed beside each one
- Sells eight tracked compounds as single products rather than only inside combinations
- Names its corporate entity plainly in its own terms
Trade-offs
- Every figure is a floor written as "from", so no product has a quoted rate a buyer can hold it to
- Five products price a multi-peptide stack at one figure, which cannot be compared against a single-compound price
- No pharmacy is named — the site refers to partner pharmacies as a category
- No service area is published anywhere on the site, including in its terms
42. Ambiante Health and Wellness
$249/mo — the catalog's own "from" figure for the single-compound PT-141 tile, under Sexual Health & Hormones
Summary, strengths and trade-offs8 points
Ambiante Health and Wellness is the fourth seller found serving a byte-identical peptide menu under a different company and a different price list, and it prices seven tracked compounds on its own.
Strengths
- Prices seven tracked compounds individually rather than only as blends
- States that its medications are compounded in a United States pharmacy on every product card
- Says a licensed provider reviews each case before a prescription is written
- Publishes its menu without an intake wall, so the figures can be compared before signing up
Trade-offs
- Serves the same peptide menu as three other sellers on this roster under a different company
- Its own template misfiles some descriptions, so a blend can carry a single compound’s sentence
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
43. Longevixx
$249/mo — starting rate, per month
Summary, strengths and trade-offs7 points
Longevixx runs one of the wider peptide menus on this roster — twenty programs, each quoted as a monthly figure — including PT-141, epitalon and semax, which few sellers price.
Strengths
- Publishes a monthly figure beside every one of its twenty peptide programs, not a starting price for the catalog as a whole
- Prices PT-141, epitalon and semax, three compounds most sellers on this roster do not list at all
- Charges nothing when a request is turned down
Trade-offs
- Semax, KPV, TB-500 and CJC-1295 are sold only inside combination vials, so the figure beside each is the price of a pairing rather than of that peptide alone
- Its terms limit service to the states where the company operates without naming them, so coverage cannot be checked before signup
- The compounding pharmacy that fills prescriptions is not named on the site
- Every figure is a starting rate, and the catalog does not say what moves a program above it
44. ElitePhysiqMD
$260.10/mo — the catalog rate of $260.10/mo.; every figure on this catalog is the member price under a $99.00/month membership, and on the two product pages opened in full the member figure was exactly 10% below the struck-through list price ($225.00 against $250.00, $267.30 against $297.00). The list price for this item was not read on its own page and is not stated here.
Summary, strengths and trade-offs8 points
ElitePhysiqMD publishes the widest prescription peptide catalog on this roster — fifteen of the sixteen compounds this site tracks, each with a figure in visible text — and every one of those figures is a member rate that sits on top of a separate monthly membership charge.
Strengths
- The widest prescription peptide catalog on this roster, with a figure in visible text on every item
- Its product pages state that compounded preparations are not FDA-approved and that human evidence for peptides is limited, on the page taking the order
- Calls one of its weight-loss compounds investigational, which is accurate and rare
- Publishes the one-time-purchase total, the visit fee and the shipping charge as separate named lines rather than one blended figure
Trade-offs
- Every catalog figure is a member rate, and the catalog page itself never mentions the monthly membership those rates depend on
- Two of the compounds it lists are sold only inside a two-peptide stack, so neither has a price of its own
- The compounding pharmacy is described by licensing class on every page and is never named
- No state coverage list and no certificate of analysis appear anywhere in the pages read
45. Pause Rx
$299/mo — starts at, per month
Summary, strengths and trade-offs8 points
Pause Rx prices eight peptide products at a monthly rate, names Rush Pharmacy as its filler, and says on every page that it is not a pharmacy itself.
Strengths
- Names Rush Pharmacy as the pharmacy that fills its prescriptions
- Repeats on every product page that it is "not a state-licensed pharmacy nor a drug manufacturer"
- Prices five tracked compounds across eight products, injection and needle-free alike
- Charges less for the sermorelin troche than for the injection
Trade-offs
- Its GHK-Cu cream is the one product with no stated billing period
- Publishes no operating company on any page read
- Publishes no state list
- No certificate of analysis is reachable
46. Immortals
$73 — the sale price, printed beside a struck-through regular figure, with no period stated anywhere on the listing; the catalog's own headline offer is quoted per day instead
Summary, strengths and trade-offs8 points
Immortals quotes its headline offer per day over a catalog priced per item, and only one of the four tracked compounds it names carries a figure at all.
Strengths
- Names four tracked compounds as products in its own navigation
- Publishes a figure on its own site with the unit recorded beside it
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its headline figure is quoted per day, a unit nothing else here can be compared against
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
47. Heva Health
$89 — for the men’s formula; the shop page states no billing period
Summary, strengths and trade-offs8 points
Heva Health sells peptides by the vial from an open shop page, and its PT-141 figure is one of the lowest anywhere on this roster.
Strengths
- Publishes the volume of every vial beside its price
- Runs an open shop page rather than quoting only after an intake
- Names Heva Health LLC as the operating company
- Says its medications are "FDA-approved or compounded at FDA-registered, state-licensed pharmacies"
Trade-offs
- No figure on the shop page carries a billing period
- Its "licensed in all 50 states" line describes the clinician, not the service area
- Publishes no state list of its own and names no dispensing pharmacy
- No certificate of analysis is reachable
48. Peaks Curative
$139.99 — a one-time price; a subscription is offered at $125.99 every four weeks
Summary, strengths and trade-offs8 points
Peaks Curative carries a February 2026 federal warning letter, names its pharmacy, and tells readers in one place that its treatments are FDA-approved and in another that compounded products are not.
Strengths
- Names its dispensing pharmacy as a legal entity
- Lists the nine states its doctors and pharmacy are licensed in
- Prints the vial size, the concentration and the sprays per bottle beside each figure
- Offers PT-141 as a nasal spray with a one-time price beside the subscription
Trade-offs
- Carries a February 2026 federal warning letter naming its own website
- Says its treatments are FDA-approved on one page and that compounded products are not on another
- Three of its four prices appear only on a category listing, not on the product page
- Its checkout offers a fifty-state dropdown while it names nine licensed states
49. BioGlow Health
$159 — the price beside "~1 month supply"; filed by the shop under ED rather than under peptides
Summary, strengths and trade-offs8 points
BioGlow Health puts every peptide figure in visible text on an open shop page with no account gate, and then describes two of its three nasal sprays with the word "Injectable" — the injection copy pasted onto the nasal listing.
Strengths
- Every product figure sits in visible text on an open shop page — no account, no quiz and no blur between a reader and the price
- Publishes a dose ladder for its GLP-1 line rather than one headline figure, which is the same transparency applied to a different lane
- Runs the whole site in English and Spanish from a header toggle
- Claims fifty-state service for itself in its own footer
Trade-offs
- Two of its three nasal-spray listings — NAD+ and glutathione — describe themselves as injectable, so the delivery copy contradicts the product name
- Every price is labeled "~1 month supply" with a tilde and no billing cycle, so no figure is a quoted monthly charge
- The compounding pharmacies are described only as licensed and are never named
- Lab panels are required by its own process description but are not stated to be included in any price
50. Regenics
$159 — member price on the 10 mg vial ($249 non-member); the 20 mg vial is $299 member / $399 non-member
Summary, strengths and trade-offs9 points
Regenics prints two figures for every peptide it sells — a list price and a lower member price — and the member price is the only one a buyer can reach, because the catalog itself says ten further peptides are visible only after a $39-a-month membership.
Strengths
- Prints the non-member figure beside the member figure on every peptide page, so the discount is visible rather than implied
- Says on the NAD+ page that the compound is "Not FDA-approved for weight loss or athletic performance", which is a scoping most sellers leave out
- Its sermorelin page states plainly that adult wellness use is off-label and that the evidence for it is limited
- Sells GHK-Cu as a prescribed compounded cream and says so, rather than as a cosmetic jar
Trade-offs
- The full peptide catalog is behind a paid membership — the site says ten further peptides are member-only and names none of them
- Every published figure is a member rate that sits on top of a $39-a-month membership charge
- Its NAD+ page shows no price at all until a potency is selected, so the page reads as priceless on arrival
- Two of its own pages describe the same sermorelin item at two different strengths
- The 503A compounding pharmacy is never named, and no service-state list is published anywhere
51. Nex Gen Health Rx
$189 — from; the product page states no billing period
Summary, strengths and trade-offs8 points
Nex Gen Health Rx names its dispensing pharmacy, prices four tracked compounds, and states a period for none of them.
Strengths
- Names Manifest Pharmacy rather than describing an unnamed accredited one
- Publishes a PT-141 figure, which most of this roster does not
- Prices glutathione to the cent instead of rounding to a marketing number
- Cross-links each product to the others from within the product page
Trade-offs
- None of its four figures carries a billing period
- Publishes no operating company on any page read
- Its sermorelin price is published on a testosterone product page rather than a sermorelin one
- Publishes no state list and no certificate of analysis
52. FancyMeds
$199 — billed every four weeks; the same eight-week treatment is $375 as a one-time payment
Summary, strengths and trade-offs8 points
FancyMeds carries a 2025 federal warning letter, names two pharmacies — one of which carries a letter of its own — and puts the other drug's price card directly under each product's own.
Strengths
- Names two dispensing pharmacies, one by its legal entity and its trading name
- Publishes an installment price and a one-time total for the same treatment
- States the titration schedule and the treatment length beside each figure
- Prices PT-141 and glutathione, which most sellers here do not price at all
Trade-offs
- Each product page carries a cross-sell card holding the other drug's price
- Its own FAQ heading about state availability has no answer in the page
- Its four-week installment is not a month, though it reads like one
- Carries a 2025 federal warning letter naming its own website, and one of its two named pharmacies carries a separate federal letter for adulterated drug products
53. Harmony Wellness Clinic
$200 — the only price line on the page with no supply length attached
Summary, strengths and trade-offs8 points
Harmony Wellness Clinic prices its peptides by supply length rather than by month, and three of its four supply lengths are not a month.
Strengths
- Attaches a supply length to almost every figure instead of printing a bare number
- Prices eleven tracked compounds on one open services page
- Says its prescriptions "may include FDA-approved medications or compounded formulas, which are not reviewed by the FDA"
- Names the regulatory class of its suppliers — 503A pharmacies licensed by state boards
Trade-offs
- Charges the same $200 for a five-week supply and a one-month supply of different compounds
- Its PT-141 price names no supply length at all
- Publishes no operating company, no state list and no named pharmacy
- No certificate of analysis is reachable
54. YourHealthRx
$209 — printed as 'PT-141 · As low as $209/mo' in the sexual-health goal panel, under the same condition
Summary, strengths and trade-offs8 points
YourHealthRx prints a rate against five separate peptides and conditions every one of them on a promotional code or a six-month commitment that expires on a stated date.
Strengths
- Publishes a rate for five distinct peptides rather than one blended protocol
- States the condition attached to its rates instead of hiding it after intake
- Prints an expiry date on the promotion rather than running it indefinitely
- Groups its catalog by goal so a reader can find the compound for their purpose
Trade-offs
- Not one advertised rate is a plain month-to-month price
- Every figure requires a promotional code or a six-month supply, or both
- Its own page says it does not prescribe and routes to partner workflows, leaving unclear whether it is the seller
- Publishes no state list and names no dispensing pharmacy
55. Lyfe Rx
$225 — a bare storefront figure; the listing names no billing period
Summary, strengths and trade-offs8 points
Lyfe Rx carries a 2025 federal warning letter naming its own website, and today publishes a flat storefront price for bremelanotide and for two glutathione products with no billing period stated anywhere on the listing.
Strengths
- Puts a figure beside every product in an open storefront rather than behind an intake
- States in its own words that compounded drugs are not reviewed by the FDA and are not generic equivalents
- Says plainly that it is a telehealth platform and not a pharmacy
- Sells bremelanotide under its molecule name rather than a brand alias
Trade-offs
- Carries a 2025 federal warning letter that names its own website address
- Prints no billing period beside any storefront figure, so no price here is a monthly one
- Lists a nasal spray and a "protocol" at different prices for the same compound without saying what separates them
- Names no dispensing pharmacy and publishes no certificate of analysis
56. Nip & Tuck Wellness Institute
$335 — printed as 'PT-141 (The Spark Shot) - Starting at $335+', a floor rather than a rate
Summary, strengths and trade-offs8 points
Nip & Tuck publishes a figure against each of eight compounds and its own overall range in words — and prints two different sermorelin prices on the same page.
Strengths
- Publishes a figure for eight separate tracked compounds on one page
- States its own overall price range in plain words rather than leaving it to be inferred
- Prices oral and injectable forms of the same compound separately
- Prices multi-peptide stacks separately from the single compounds inside them
Trade-offs
- Publishes two different sermorelin figures on one page with no explanation
- Almost every figure is a floor marked with a plus sign rather than a settled rate
- Publishes no corporate entity, only a named physician
- Publishes no state list and names no dispensing pharmacy
57. WePeptideRx
$459 — all-in for 30 mg total, listed against $499; the provider sets the cadence, so no period applies
Summary, strengths and trade-offs8 points
WePeptideRx prices three peptides per month supply on one page and prices PT-141 only as a fixed-milligram bundle, so its cheapest and dearest figures are not comparable.
Strengths
- Prints "per month supply" beside its three main figures rather than a bare number
- States the milligram total behind every bundle price
- Says the provider consultation, medication and shipping are included with no separate fees
- Describes itself as LegitScript-certified telehealth in its own words
Trade-offs
- Publishes no operating company on any page read
- Its PT-141 and NAD+ bundles carry no period, so they cannot be compared to its monthly rows
- Answers 200 at a nonsense path, so absence cannot be proven from status alone
- Publishes no state list, no named pharmacy and no certificate of analysis
58. AgeRejuvenation
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
AgeRejuvenation names fourteen tracked compounds on one peptide page, the deepest single menu in this batch, and does not price a single one of them.
Strengths
- Names fourteen tracked compounds on one page, the deepest single menu here
- Names its operating company on two separate legal pages
- Runs separate NAD+ and glutathione pages beneath the main peptide menu
- Covers KPV, semax, epitalon and MOTS-c, which most rosters miss entirely
Trade-offs
- Carries no figure on its peptide menu or on any compound page
- Its legal name is tied to one location while the brand is presented as regional
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
59. the biostation
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
the biostation links per-compound fact sheets from its peptide page, and one of the two, fetched directly, answers successfully with an empty file.
Strengths
- Publishes per-compound reading material of its own, which most sellers here do not
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- One of the two linked documents answers with an empty file, and neither is a certificate
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
60. Companion Health
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Companion Health publishes its operator as a professional limited liability company on four separate pages, which is more than most sellers here manage, and no price on any of them.
Strengths
- Publishes its operator in a professional-corporation form on four separate pages
- Names five distinct compounds including PT-141
- Describes itself as concierge medicine rather than a subscription storefront
- Returns a clean hard error for a path that does not exist
Trade-offs
- Carries no figure on any page read
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
- Exposes a small site, so little can be cross-checked
61. Della Bellezza Med Spa
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Della Bellezza names sixteen compounds on one service page, eleven of them ones this site tracks, and its own storefront — open to the public — sells skincare rather than any of them.
Strengths
- One of the widest single-page compound lists on this roster
- Declares eleven of the sixteen compounds this site tracks on pages a reader can reach
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its own storefront is open and sells skincare, so the breadth is a menu with nothing priced behind it
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
62. EdgeRx
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
EdgeRx sells the same compound in two needle-free formats at the same monthly price, and says in its own words that it is "not the peptide gray-market".
Strengths
- Charges the same monthly figure for the nasal and sublingual route of a compound
- Groups its catalog by goal and prints a protocol count beside each group
- Says its GHK-Cu topical is "pharmacy-compounded, not the OTC version"
- Attaches the month to every protocol figure it publishes
Trade-offs
- Publishes no operating company on any page read
- Its PT-141 and glutathione lines are sold inside multi-protocol categories with no single figure
- Publishes no state list and names no dispensing pharmacy
- Says its compounds are "tested for purity" but publishes no certificate of analysis
63. iThriveMD
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
iThriveMD prints a non-member and a member price for every peptide it sells, and the member price is between a half and a fifth of the other.
Strengths
- Prints the member and non-member figure together instead of only the discounted one
- Says its compounding happens "under Section 503A in a USP <797>-compliant sterile cleanroom"
- Operates in-person clinics as well as telehealth and says so
- States that compounded drugs "have not been reviewed or approved by the FDA"
Trade-offs
- None of its figures carries a billing period
- Its cheapest prices require buying a separate hormone or weight-loss plan first
- Answers 200 at every path, so nothing about the site can be proven absent
- Publishes no operating company, no state list and no named pharmacy
64. Modern Wellness Clinic
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Modern Wellness Clinic names eight tracked compounds on one service page and tells readers, in its own words, that many of its patients arrive after buying peptides from research chemical companies with no medical oversight.
Strengths
- States plainly, on the page selling the treatment, what it thinks of the unsupervised market
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its own linked storefront serves a page with no products, so nothing is priced anywhere
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
65. Neo Soma Healthcare
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Neo Soma states a dose schedule next to each monthly refill price, which is rarer here than the price itself — but both figures are sale figures running against a countdown clock.
Strengths
- States the dose and weekly frequency beside the price, not just a product name
- Labels both peptide figures as monthly refills rather than leaving the period unstated
- Names its operating company on two separate legal pages
- Keeps its two peptide products on separate pages with separate figures
Trade-offs
- Both published figures are promotional and sit beside a struck-through regular figure
- A running countdown means the figure a reader sees may not be the figure they are charged
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
66. Relive Health
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Relive Health's terms name a franchising company rather than a clinical one, so the party on the other side of the contract is the brand owner.
Strengths
- Names the contracting company and publishes a postal address for it
- Names the company on the other side of the transaction rather than only a trading name
- Declares nine of the sixteen compounds this site tracks on pages a reader can reach
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its terms carry a last-modified date from nearly three years before this reading
- Publishes no figure for any compound on the pages read
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
67. Spa Sydell
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Spa Sydell organizes its peptide menu three ways — by compound, by blend and by concern — and prices none of them; the numbers on its site belong to its skincare shop.
Strengths
- Lets a reader browse peptides by individual compound, by blend or by concern
- Names eleven tracked compounds across its browse pages
- Keeps its retail shop on separate pages from its therapy menu
- Returns a clean hard error for a path that does not exist
Trade-offs
- Carries no figure on any of its four peptide browse pages
- Publishes no corporate entity on any page read
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
68. VEVArx
$247/mo — per month on the flexible monthly plan; the three-month plan is $663 total, stated as $221/month
Summary, strengths and trade-offs8 points
VEVArx sells peptides only as three-month plans and prints the total and the per-month equivalent together, except for PT-141, which it also sells monthly.
Strengths
- Prints the prepaid total and the per-month equivalent on the same card
- Offers PT-141 month to month as well as on a three-month plan
- States plainly that compounded medications are not approved by the FDA
- Lists what each plan includes rather than only what it costs
Trade-offs
- Sells sermorelin, glutathione and NAD+ only in three-month blocks
- Publishes no operating company on any page read
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
69. Vital Edge
$249/mo — per month, flat regardless of dose, with consultation and shipping included — the card prints "then $249/month"
Summary, strengths and trade-offs8 points
Vital Edge hides a five-compound peptide price list behind a tab on its homepage — nothing about peptides renders until that tab is clicked — and serves a different toll-free number on every page load.
Strengths
- States that the monthly fee is flat regardless of dose, so titrating up does not raise the bill
- Says the figure covers consultation, medication and shipping rather than medication alone
- Publishes what happens if treatment is declined: "If medication isn't prescribed, the tele-health consult fee is $80"
- Prices its GLP-1 line in the open too, brand and compounded side by side
Trade-offs
- Nothing about peptides renders until a tab is clicked, so the peptide prices are invisible on arrival
- A different toll-free number is served on each page load, so the contact number a reader notes down is not stable
- Names no compounding pharmacy and publishes no service-state list
- Its GHK-Cu card names no delivery format, so a reader cannot tell whether the figure buys an injection or a cream
70. Try Invigor
$280/mo — per month, as the plan page states it; the consultation and the supplies are included in the figure
Summary, strengths and trade-offs8 points
Try Invigor names its operating company, its clinical groups and a street address, and prices four tracked compounds on plan pages — three of which name a billing period and two of which name none at all.
Strengths
- Names the operating company, its trading name and a service address in its own arbitration clauses, and names California as the governing law
- Names the two clinical groups it works with, separately from the company that runs the website
- Says in its own footer that it does not prescribe for bodybuilding, athletic performance or cosmetic purposes, which is a narrower scope than most sellers here claim
- Prices each compound in an injectable and an oral or nasal form on separate plan pages
Trade-offs
- Two of its five plan pages print a figure with no billing period at all, while the other three say per month
- The privacy policy still names a website address the company no longer serves
- No state coverage list, and the compounding pharmacy that fills an order is not named
- No lab work is described as included in any plan figure
71. eDrugstore
$99 — total price; the same panel prints a per-dose figure of $9.90 and names no billing period
Summary, strengths and trade-offs8 points
eDrugstore prices three tracked peptides as flat catalog items with a total and a per-dose figure side by side, and carries a 2025 federal warning letter naming its own domain.
Strengths
- Puts a total and a per-dose figure side by side on every product page, so the unit is explicit
- States the supply length on the vial product rather than leaving the quantity implied
- Publishes a street address and staffed ordering hours a reader can check
- Lists three tracked compounds as ordinary catalog items rather than behind an intake
Trade-offs
- Carries a federal warning letter that names this exact domain
- Describes the pharmacy that fills an order only by accreditation, never by name
- Publishes no state list, so eligibility is settled after the order starts
- Sells the required blood test as a separate line item rather than including it
72. MintRx
$180 — 30-day supply, in the seller's own words
Summary, strengths and trade-offs8 points
MintRx publishes the most specific price disclosures in this batch — a strength, a container size and a supply length beside almost every figure — and names no operating company anywhere on its site.
Strengths
- Prints a strength, a container size or a spray count beside almost every figure, which is a more specific disclosure than most sellers here manage
- Names a 28-day supply and a 28-day refill cadence on its sermorelin cards rather than rounding either to a month
- Sells four tracked compounds in both an injectable and a non-injectable form, so the two routes can be compared on price directly
- Publishes a telephone number and a HIPAA notice alongside its terms and privacy policy
Trade-offs
- No operating company is named anywhere on the site — no corporate form, no street address, and no governing-law clause in the terms
- Six of its seven longevity and sexual-health products print their price only on another product's card, so a reader on one product page may see every figure except that product's own
- The same figure covers both PT-141 products on different terms, one described as a 30-day supply and the other as a single prescribed order
- No state coverage list, and the compounding pharmacy that fills an order is never named
73. RyzeRx
$199 — the product-page price for "PT-141 (Bremelanotide)", printed as "$199 USD" beside "Add to cart" with no billing period, supply length or vial size
Summary, strengths and trade-offs9 points
RyzeRx prices every product on its own page, from single peptides to vial-by-vial weight-loss strengths, and says on none of them what period or supply the figure buys.
Strengths
- Puts a figure on every product page, from single peptides to each weight-loss vial strength
- Publishes its site in English and Spanish from the same navigation
- Says its medicines come from United States licensed pharmacies
- Offers a free consultation before any commitment
Trade-offs
- No product page says what period or supply its figure buys, though its terms say subscription plans renew automatically
- Its homepage cards still lead with category starting figures that none of the named peptides carries
- Its fifty-state lines are a marketing statistic and a statement about provider licensure, not a coverage statement
- Names no dispensing pharmacy and no certificate of analysis is reachable
- The support phone line in its terms, "(800) 555-0123", has the shape of a placeholder number; the cancellation route the terms actually name is email
74. Celia Rx
$249 — Per item with no period stated — "PT-141 (Bremelanotide) Nasal Spray $249.00"; the lozenge is the same $249.00
Summary, strengths and trade-offs8 points
Celia Rx runs an open storefront where every peptide carries a flat item price and the onboarding consultation is a line item of its own — and where one nasal spray is dearer than a bottle six times its concentration.
Strengths
- Publishes an open storefront with every item priced, rather than putting prices behind an intake
- Prices the onboarding consultation as its own line and states how long it is
- Prices every route of a compound rather than one headline form
- Names its operating company in the opening sentence of its terms
Trade-offs
- No item carries a billing period, so nothing on the storefront is comparable to a monthly rate
- Its oxytocin lines make the smaller bottle cheaper and far more concentrated, which reverses any per-milligram ranking
- Names no dispensing pharmacy, describing it only as "a qualified 503A pharmacy"
- Publishes no state coverage
75. The HCG Institute
$329 — "PT-141 Bremelanotide Injections $329.00" in the storefront catalog, with no supply period stated
Summary, strengths and trade-offs8 points
The HCG Institute runs a forty-three item storefront where four of the compounds compared here carry list prices, states in a dropdown what each program length adds to the base figure, and names the one state it cannot ship to.
Strengths
- Publishes a list price against every one of forty-three catalog items
- Prints the longer-program cost as an uplift on the base figure rather than as a divided rate
- Names the one state it cannot ship to on each product page
- Lists exactly what a purchase includes, item by item, so what is missing is visible
Trade-offs
- Carries a federal warning letter that names its own domain
- Publishes no price on any of its compound-named editorial pages, only inside its store
- States no supply period or strength on four of its five priced items compared here
- Names no compounding pharmacy while stating it does not compound or dispense itself
76. David Borenstein
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
This practice names twelve compounds across offices in two states and publishes no company name at all: its copyright line is a bare year.
Strengths
- Names twelve compounds, seven of them tracked here, on one service page
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Publishes no company name anywhere — the copyright line carries a year and nothing else
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
77. Dvida Spa
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Dvida tells readers, on its own peptide page, that two of the compounds it lists there appear on the FDA's bulk drug substances warning list and are not approved for human use.
Strengths
- Names the FDA bulk substances warning list against two compounds on its own menu, on the page selling them
- Answers "are peptides FDA-approved" with the word "No" and then explains
- Names its operating company in the first line of its terms
- Distinguishes compounded GLP-1s from branded products in the same note
Trade-offs
- Publishes no price for anything
- Publishes no state coverage and names no dispensing pharmacy
- Its own product URL carries a spelling error that a reader retyping the address will not reproduce
- The disclosure is strong but the catalog detail behind each compound is thin
78. Executive Medicine of Texas
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Executive Medicine of Texas names eleven tracked compounds in a service page of about six and a half thousand characters, one of the densest declared lists on this roster.
Strengths
- Names eleven tracked compounds in a page short enough to read in full
- Declares eleven of the sixteen compounds this site tracks on pages a reader can reach
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Its own terms page names no company, so the absence rests on the page that should have carried it
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
79. Fit MD
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Fit MD puts three of its four tracked compounds in its own page title and prices none of them; the peptide line sits inside its hormone practice rather than beside it.
Strengths
- Names its compounds in the page title, so a reader searching for one lands on confirmation
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- The page describes the category rather than the products, and carries no figure
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
80. Focal Point Vitality
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Focal Point Vitality carries eleven tracked compounds in its own navigation, including KPV and semax, and no price behind any of them.
Strengths
- Carries eleven tracked compounds in its navigation, including KPV and semax
- Exposes a deep, followable site rather than a single landing page
- Names compounds most local clinics do not stock, such as epitalon and MOTS-c
- Returns a clean hard error for a path that does not exist
Trade-offs
- Carries no figure on any page read
- Publishes no corporate entity anywhere
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
81. Gameday Men's Health
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Gameday is a franchise operator, not a clinic — its terms name the franchising company as the party you contract with, and it refers to its own "Pharmacy Network" without naming a pharmacy in it.
Strengths
- Names the franchising company that actually owns and operates the site, in the terms' opening paragraph
- Publishes a per-compound service page for sermorelin and another for PT-141
- Publishes a notice address a reader can write to
- Distinguishes services it provides from services provided by affiliated practices
Trade-offs
- Publishes no price on any page read
- Refers to its own "Pharmacy Network" without naming a single pharmacy in it
- A franchise network means the clinic a reader visits is not the company they contracted with
- Publishes no state coverage
82. Glowlight Med Spa
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Glowlight's peptide page carries eight dollar figures and every one of them also renders on its privacy policy, which is what proves none of them prices a peptide.
Strengths
- Names five tracked compounds and keeps its weight-loss program visibly separate from them
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Every figure on the peptide page is a site-wide promotion that also renders on the privacy policy
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
83. Houston Men's Clinic
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Houston Men's Clinic trades under one name and puts a different one in its copyright line, with no corporate form attached to either.
Strengths
- Names four tracked compounds as services on a page a reader can take in at once
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Publishes two trading names that do not match and no registered company behind either
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
84. Lumora
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Lumora runs a medication page per compound and a condition page per goal, and prices neither — its only published figure sits inside a liability clause.
Strengths
- Organizes its catalog by medication and by condition rather than by marketing bundle
- Names its operating company on three separate legal pages
- Routes a reader into a condition assessment rather than straight to a cart
- Publishes a separate data-privacy page beyond the standard privacy policy
Trade-offs
- Publishes no figure on the medication page for the peptide it sells
- Its brand name and legal name share no words, and the terms print two variants of the legal name
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
85. MetroMed Health
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
MetroMed names eleven tracked compounds and sells some of them as kits, on a page that is nearly two megabytes of markup wrapped around about eight thousand characters of text.
Strengths
- Names eleven tracked compounds and runs a separate page for the kits it bundles them into
- Declares eleven of the sixteen compounds this site tracks on pages a reader can reach
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- A kit is not a per-compound unit, and no figure is published on either page
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
86. Mojo Vitality
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Mojo Vitality names seven compounds including PT-141 and tesamorelin on a three-page site, and publishes no figure on any of them.
Strengths
- Names seven distinct tracked compounds on a small site
- Names its operating company in the footer of every page served
- Includes PT-141 and tesamorelin rather than only the common growth-hormone peptides
- Returns a clean hard error for a path that does not exist
Trade-offs
- Carries no figure on any page served
- Exposes only three followable pages, so nothing can be cross-checked
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
87. R2 Medical Clinic
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
R2 publishes a regulatory-status and evidence-strength table against its own catalog, and tells readers in that table that the clinical evidence for some of what it sells is insufficient.
Strengths
- Publishes a regulatory status and an evidence strength for each peptide it sells, in a table
- States plainly that the human evidence for some of its own catalog is insufficient
- Distinguishes an approved indication from the use it is being sold for, compound by compound
- Says its medications come from compounding pharmacies and that they are not FDA-approved for all indicated uses
Trade-offs
- Publishes no price for anything
- Publishes no corporate entity
- Names no dispensing pharmacy and publishes no state coverage
- Its 404 page is nearly twice the size of its real terms page, so nothing on this host can be judged by weight
88. REGENX Health
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
REGENX Health lists four peptides on a dedicated peptides page and puts a figure against none of them.
Strengths
- Runs a dedicated peptides page separate from its hormone lines
- Names four distinct compounds including tesamorelin and PT-141
- Names its operating company in its terms
- Returns a clean hard error for a path that does not exist
Trade-offs
- Carries no figure on any page read, including the peptides page
- Its terms page also carries a second company name that is its web agency, not an operator
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
89. Renew Vitality
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Renew Vitality names its operating company and describes itself as a telemedicine provider in its own terms, and publishes no price on any page this pass could read.
Strengths
- Names its operating company and states what kind of provider it is in the same sentence
- Carries a terms page dated within six months, which most of this batch does not
- Publishes a dedicated sermorelin therapy page under its hormone service
- Says its prescribers build a plan combining approved and compounded medications
Trade-offs
- Publishes no price for anything
- Names no dispensing pharmacy
- Publishes no state coverage
- The peptide pages sit several levels below the hormone service, so the catalog is hard to take in at once
90. Revitalize IV Solutions
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Revitalize lists seventeen peptides on a page with no prices on it, prices two of them on a different page, and publishes the rest of the menu as a downloadable PDF — which does resolve.
Strengths
- Publishes a downloadable peptide menu from its own page, and the file actually resolves
- Prices its IV and injection lines in detail, with the gram options named
- Names seventeen peptides on one page, one of the widest declared catalogs in this batch
- Prices facial, IV, injection and laser lines on one public page
Trade-offs
- The peptide page itself contains no price at all — a reader has to find the pricing page or the PDF
- Only two of the fourteen compounds this site tracks carry a published figure
- Publishes no corporate entity; the footer has a year and no name
- Names no dispensing pharmacy and publishes no state coverage
91. Rewind Anti-Aging of Miami
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Rewind Anti-Aging of Miami gives seven compounds their own service pages and prices none of them — and shares nothing but a brand word with the Rewinding RX already on this roster.
Strengths
- Publishes a service page per compound rather than one combined menu
- Names its operating company consistently on every page read
- Names ten tracked compounds including MOTS-c and tesamorelin
- Keeps its peptide pages separate from its weight-loss line
Trade-offs
- Carries no figure on any of the eight pages read
- Its brand words collide with an unrelated company already on this roster
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in what it charges
92. Sage Wellness & Health
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Sage Wellness runs a numbered twenty-two entry per-compound library on its own domain, the largest structured compound reference any single seller on this roster publishes.
Strengths
- Publishes a numbered per-compound library on its own domain, each entry with its own address
- Declares eleven of the sixteen compounds this site tracks on pages a reader can reach
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- The most detailed reference surface here and no figure anywhere on it
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
93. Serotonin Centers
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Serotonin Centers is a franchised clinic chain that publishes one figure across its whole peptide and NAD+ menu — a monthly NAD+ membership with a stated supply length — and prices nothing else it sells.
Strengths
- Publishes a monthly membership figure with the supply length stated inside it rather than a bare rate
- Says outright that individual session pricing depends on delivery method and plan, instead of implying one exists
- Names its operating company and its trading name in its own terms
- Runs physical clinics, so a buyer who wants an in-person infusion rather than a mailed vial has that option
Trade-offs
- Prices nothing on its peptide menu — sermorelin and PT-141 are described at length with no figure anywhere
- A franchise of independently owned centers, so a corporate-page figure need not be the price at any one clinic
- Publishes no service-state list, only a clinic locator, so mail-order eligibility cannot be checked
- Names no compounding pharmacy anywhere on the peptide or NAD+ pages
94. Strong Health
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Strong Health writes the research-use distinction into its own sales copy and puts a page behind each of eleven compounds, then prints no figure on any of them.
Strengths
- States in its own words that it will never supply a research-use vial
- Publishes a page per compound rather than a single undifferentiated peptide menu
- Publishes a comparison table naming the alternatives it is arguing against
- Says baseline and monitoring bloodwork are part of its model
Trade-offs
- Carries no figure on any of the seven compound pages read
- Publishes no corporate entity anywhere on those pages
- Publishes no state list and names no dispensing pharmacy
- Its comparison table describes rivals in categories it defines itself
95. VitalRenew Clinic
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
VitalRenew names nine tracked compounds in about five thousand characters, and only one of them has a page of its own.
Strengths
- A dense declared list on a single page a reader can finish
- Declares nine of the sixteen compounds this site tracks on pages a reader can reach
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- Only one compound has any depth behind it; the rest are names on a list
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
96. YOURx Health
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
YOURx Health prices six tracked peptides by the month on one protocol page, and sells every one of its weight-loss medicines combined with vitamin B12, so none of those four carries a price scoped to the drug.
Strengths
- Prices six tracked peptides individually, each on its own card with its own figure
- Names YOURx Health LLC as the operating company in its footer
- Marks products that are not yet available as coming soon rather than selling them
- Says on the BPC-157 card that lab work is required before a prescription
Trade-offs
- Every weight-loss product is combined with vitamin B12, so none carries a price scoped to the drug
- Sells PT-141 only inside a three-ingredient troche
- Publishes no state list and names no dispensing pharmacy
- No certificate of analysis is reachable
97. Apollo Virtual Health
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Apollo Virtual Health names four tracked compounds on a single short page and pads the list with nothing it does not carry.
Strengths
- A short catalog that can be read in full in a couple of minutes
- Describes what it offers without claiming an approval it does not have
- Keeps its peptide offer separate from its other lines on the page
- Answers the category question in plain language rather than in a disclaimer
Trade-offs
- No company name, no state list and no figure anywhere on the pages read
- Publishes no figure for any compound on the pages read
- Publishes no corporate entity, so there is no company a reader can look up
- Publishes no state list and names no dispensing pharmacy
98. SynergenX Health
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
SynergenX publishes a page on who should not take peptides, which almost no seller here does, and no figure on either of the two peptide pages it runs.
Strengths
- Publishes a dedicated page on who should not take peptides
- Gives sermorelin and PT-141 their own pages rather than one combined menu
- Names its operating company on its privacy policy
- Operates named physical locations rather than a purely virtual front
Trade-offs
- Carries no figure on either peptide page
- The only published figure on the site is for hormone testing, not for a peptide
- Publishes no state list and names no dispensing pharmacy
- Describes no lab work as included in a peptide price, because there is no peptide price
99. telos rx
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
telos rx names its operating company beside its brand in the footer and names sixteen peptides on one page — and publishes no figure on that page for any of them.
Strengths
- Names the operating company beside the brand in its own footer
- States the regulatory position in short, unhedged sentences
- Names twelve compounds this site tracks on a single page
- Publishes editorial about the peptides rather than only product cards
Trade-offs
- No figure appears on the page read, although the page links its own pricing anchor
- The catalog and the checkout live somewhere this pass did not reach
- Names no dispensing pharmacy
- Publishes no state coverage
100. Viking Alternative Medicine
Does not publish a PT-141 price.
Summary, strengths and trade-offs8 points
Viking runs a pricing page that refuses to price, and says why in words worth quoting — what it publishes instead is what it says its patients typically pay, which is not the same thing.
Strengths
- Says in its own words why it will not publish a flat rate, instead of publishing a rate that is not one
- Publishes what it says most patients actually pay, with the period attached
- Prices its missed-appointment charge, which most of this roster leaves unstated
- Names ten peptides across its own FAQ and dedicated compound pages
Trade-offs
- Publishes no price for any compound — the range on the pricing page describes patients, not products
- Publishes no corporate entity
- Names no dispensing pharmacy and publishes no state coverage
- A reader who takes the bottom of its patient range as a price will be quoting the wrong kind of number